ethyl 8-[3-(indolylmethyl)phenyl]-8-oxooctanoate, 97.0%, 1g

2-phenyl-1,2,3,4-tetrahydroquinoline, 95%, 250mg

2,6-DICHLORO-3-METHOXYPYRAZINE, 95.0%, 1g

4-(((2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)benzonitrile, 95+%, 5g

tert-butyl methyl ether, min. 99.5%, for synthesis, 1 l, glass packaging

4,4'-Dichlorocarbanilide, 95.0%, 1g

4-(Trifluoromethyl)-dl-phenylalanine, 97.0%, 100mg

Methyl 4-bromo-2-fluoro-6-hydroxybenzoate, 95.0%, 10g

N-(4-Bromophenyl)-3-oxobutanamide, 95.0%, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid, 95%, 5g

N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide Hydrochloride>98.0%(HPLC)(N)100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine, 98.0%, 1g

4-(Methoxycarbonyl)thiophene-2-carboxylic acid, 98%, 5g